84 related articles for article (PubMed ID: 1626165)
1. [Clinical usefulness of the glucagon test in the study of pancreatic islet cell function].
Llorente I; Goñi MJ; Forga L; Monreal M; Lizcano F; Moncada E
Rev Med Univ Navarra; 1992; 37(1):25-9. PubMed ID: 1626165
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of beta cell function in non-insulin-dependent diabetes mellitus (NIDDM) and its correlations with clinico-metabolic parameters].
Santoro E; Gianni R; Maggi L; Tomassini CR; Bisacchi U
G Clin Med; 1989 Feb; 70(2):95-9. PubMed ID: 2666224
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of measuring serum c-peptide before and after glucagon injection].
Kan Y; Chi Z
Zhonghua Yi Xue Za Zhi; 1991 Jan; 71(1):16-7, 4. PubMed ID: 1850647
[TBL] [Abstract][Full Text] [Related]
4. The role of diminished beta cell reserve and insulin resistance in secondary sulfonylurea failure of type 2 diabetes mellitus.
Rattarasarn C; Thamprasit A; Leelawattana R; Soonthornpun S; Setasuban W
J Med Assoc Thai; 2001 Dec; 84(12):1754-62. PubMed ID: 11999824
[TBL] [Abstract][Full Text] [Related]
5. T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes.
Goel A; Chiu H; Felton J; Palmer JP; Brooks-Worrell B
Diabetes; 2007 Aug; 56(8):2110-5. PubMed ID: 17473222
[TBL] [Abstract][Full Text] [Related]
6. [Islet beta-cell function in failures following sulfonylurea therapy in diabetics, by determination of serum C-peptide].
Costamaillere L; Arteaga A; Velasco N; Pellegrino MR; Foradori A; López G; Acosta AM
Rev Med Chil; 1984 Dec; 112(12):1206-13. PubMed ID: 6399604
[No Abstract] [Full Text] [Related]
7. Estimation of B-cell function by the urinary excretion rate of C-peptide in diabetic patients: comparison with C-peptide response to glucagon and to a mixed meal.
Pasquali R; Buratti P; Biso P; Patrono D; Capelli M; Pasqui F; Melchionda N
Diabete Metab; 1987 Feb; 13(1):44-51. PubMed ID: 3552774
[TBL] [Abstract][Full Text] [Related]
8. Encainide-induced diabetes: analysis of islet cell function.
Winter WE; Funahashi M; Koons J
Res Commun Chem Pathol Pharmacol; 1992 Jun; 76(3):259-68. PubMed ID: 1636050
[TBL] [Abstract][Full Text] [Related]
9. Secretory protein 7B2 response to oral glucose loading and intravenous glucagon injection in patients with diabetes mellitus.
Hisatomi A; Natori S; Iguchi H; Ohashi M; Umeda F; Nawata H
Fukuoka Igaku Zasshi; 1996 Dec; 87(12):266-73. PubMed ID: 9011109
[TBL] [Abstract][Full Text] [Related]
10. [The diagnostic value of serum C-peptide determination].
Kober G; Rainer OH
Acta Med Austriaca; 1983; 10(2-3):67-70. PubMed ID: 6349209
[TBL] [Abstract][Full Text] [Related]
11. Residual B-cell function in insulin dependent (Type 1) and non insulin-dependent (Type 2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes).
Gerö L; Korányi L; Tamás G
Diabete Metab; 1983 Sep; 9(3):183-7. PubMed ID: 6360742
[TBL] [Abstract][Full Text] [Related]
12. C-peptide response to glucagon in diabetics with and without complications.
Smith RB; Pyke DA; Watkins PJ; Binder C; Faber OK
N Z Med J; 1979 Apr; 89(634):304-6. PubMed ID: 377156
[TBL] [Abstract][Full Text] [Related]
13. Beta-cell response to intravenous glucagon in African-American and Hispanic children with type 2 diabetes mellitus.
Taha DR; Castells S; Umpaichitra V; Bastian W; Banerji MA
J Pediatr Endocrinol Metab; 2002 Jan; 15(1):59-67. PubMed ID: 11822582
[TBL] [Abstract][Full Text] [Related]
14. Pulsatile insulin delivery is more efficient than continuous infusion in modulating islet cell function in normal subjects and patients with type 1 diabetes.
Paolisso G; Sgambato S; Torella R; Varricchio M; Scheen A; D'Onofrio F; Lefèbvre PJ
J Clin Endocrinol Metab; 1988 Jun; 66(6):1220-6. PubMed ID: 3286673
[TBL] [Abstract][Full Text] [Related]
15. The C-peptide response to glucagon injections in IDDM and NIDDM patients.
Poulsen S; Billesbølle P; Kølendorf K; Thorsteinsson B
Horm Metab Res; 1985 Jan; 17(1):39-40. PubMed ID: 3967844
[No Abstract] [Full Text] [Related]
16. Insulin/C-peptide response to intravenous glucagon. A dose-response study in normal and non-insulin-dependent diabetic subjects.
Snorgaard O; Hasselstrøm K; Lumholtz IB; Thorsteinsson B; Siersbaek-Nielsen K
Acta Endocrinol (Copenh); 1988 Jan; 117(1):109-15. PubMed ID: 3289292
[TBL] [Abstract][Full Text] [Related]
17. Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.
Gottsäter A; Landin-Olsson M; Fernlund P; Lernmark A; Sundkvist G
Diabetes Care; 1993 Jun; 16(6):902-10. PubMed ID: 8325204
[TBL] [Abstract][Full Text] [Related]
18. C-peptide determination in the choice of treatment in diabetes mellitus.
Koskinen P; Viikari J; Irjala K; Kaihola HL; Seppälä P
Scand J Clin Lab Invest; 1985 Nov; 45(7):589-97. PubMed ID: 3906851
[TBL] [Abstract][Full Text] [Related]
19. Basal and postglucagon C-peptide levels in Ethiopians with diabetes.
Siraj ES; Reddy SS; Scherbaum WA; Abdulkadir J; Hammel JP; Faiman C
Diabetes Care; 2002 Mar; 25(3):453-7. PubMed ID: 11874929
[TBL] [Abstract][Full Text] [Related]
20. Utility of glucagon stimulation test in type 1 diabetes after pancreas transplantation.
Hiratsuka I; Suzuki A; Kondo-Ando M; Hirai H; Maeda Y; Sekiguchi-Ueda S; Shibata M; Takayanagi T; Makino M; Fukami N; Itoh T; Sasaki H; Kusaka M; Kenmochi T; Hoshinaga K; Itoh M
Transplant Proc; 2014 Apr; 46(3):967-9. PubMed ID: 24767392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
